Loxal-Tax Trial: local intracoronary administration of paclitaxel after stent implantation for prevention of restenosis in comparison with stent implantation alone and with implantation of a paclitaxel-eluting stent
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Paclitaxel (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms Loxal-Tax
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 12 Jul 2011 Status changed from active, no longer recruiting to recruiting as reported by European Clinical Trials Database.
- 01 Aug 2009 Results published in Circulation: Cardiovascular Interventions.